Ophthalmology News and Research

RSS
Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.
Ophthalmology professor receives $60,000 RPB award to research Sjogren's syndrome

Ophthalmology professor receives $60,000 RPB award to research Sjogren's syndrome

Silicon oil appears to protect vision in patients undergoing radiation therapy for ocular melanoma: Study

Silicon oil appears to protect vision in patients undergoing radiation therapy for ocular melanoma: Study

pSivida submits MAA for Iluvien to UK MHRA

pSivida submits MAA for Iluvien to UK MHRA

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

New study may lead to in-car warning system that may provide enough time for drivers to react

New study may lead to in-car warning system that may provide enough time for drivers to react

Phase Ia clinical trial of SYL040012 for treating elevated intraocular pressure, glaucoma completed

Phase Ia clinical trial of SYL040012 for treating elevated intraocular pressure, glaucoma completed

Healthy diet can reduce age-related eye problems

Healthy diet can reduce age-related eye problems

ThromboGenics to present microplasmin Phase III trial data at 28th ASRS and 10th EURETINA Congress

ThromboGenics to present microplasmin Phase III trial data at 28th ASRS and 10th EURETINA Congress

Research findings suggest new treatment approach to improve corneal transplants

Research findings suggest new treatment approach to improve corneal transplants

pSivida's licensee submits NDA to FDA for Iluvien

pSivida's licensee submits NDA to FDA for Iluvien

A neuro-optometric rehabilitation case report

A neuro-optometric rehabilitation case report

Scientists discover characteristic amyloid plaques in retinas from Alzheimer's disease patients

Scientists discover characteristic amyloid plaques in retinas from Alzheimer's disease patients

Quark Pharmaceuticals' siRNA drug candidates featured in two presentations at Glaucoma & Retinopathies 2010

Quark Pharmaceuticals' siRNA drug candidates featured in two presentations at Glaucoma & Retinopathies 2010

AGTC, Icagen complete agreement for purchase and sale of patent rights

AGTC, Icagen complete agreement for purchase and sale of patent rights

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

QLT reports final 24-month results from Phase II RADICAL study in patients with wet AMD

QLT reports final 24-month results from Phase II RADICAL study in patients with wet AMD

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

Blind cyclists to travel from Toronto to Collingwood in support of the Foundation Fighting Blindness

Blind cyclists to travel from Toronto to Collingwood in support of the Foundation Fighting Blindness

National Cheng Kung University Hospital's Outpatient Building inaugurated

National Cheng Kung University Hospital's Outpatient Building inaugurated

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.